Previous Issue
Volume 15, May
 
 

Pathogens, Volume 15, Issue 6 (June 2026) – 3 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
30 pages, 2276 KB  
Review
Advances and Challenges in the Diagnosis of Vector-Borne Protozoal Infections in Veterinary Medicine
by Ana María Cevallos, Tomas Meraz-Tay and Roberto Hernández
Pathogens 2026, 15(6), 561; https://doi.org/10.3390/pathogens15060561 - 22 May 2026
Abstract
Vector-borne protozoal infections—including babesiosis, theileriosis, hepatozoonosis, trypanosomosis, and leishmaniosis—impose a substantial burden on livestock and companion animal health worldwide and carry important zoonotic and public health implications. Accurate diagnosis is essential yet challenging, given the diversity of parasite genera, their markedly different tissue [...] Read more.
Vector-borne protozoal infections—including babesiosis, theileriosis, hepatozoonosis, trypanosomosis, and leishmaniosis—impose a substantial burden on livestock and companion animal health worldwide and carry important zoonotic and public health implications. Accurate diagnosis is essential yet challenging, given the diversity of parasite genera, their markedly different tissue tropisms, and the uneven distribution of diagnostic resources across veterinary settings. This review provides an integrated overview of the principal diagnostic approaches available, structured around the biological logic that guides test selection in practice. Microscopic examination remains the first-line method; its strengths and limitations are discussed for intraerythrocytic parasites (Plasmodium spp., Babesia spp., Theileria spp., Cytauxzoon spp.—the latter two with additional extra-erythrocytic schizont stages in leukocytes and tissue macrophages, respectively), leukocyte-associated forms (Hepatozoon spp.), extracellular trypanosomes, and tissue-stage parasites, including emerging applications of artificial intelligence. Serological methods—enzyme-linked immunosorbent assay (ELISA), indirect fluorescence antibody test (IFAT), and point-of-care lateral flow assays—are evaluated for their role in exposure detection, population screening, and international trade certification, with attention to cross-reactivity and the active-versus-past-infection distinction. Molecular diagnostics, encompassing conventional PCR, qPCR, droplet digital PCR, isothermal amplification, and next-generation sequencing, are reviewed with respect to target selection, sensitivity, and point-of-care applicability. Finally, diagnostic challenges are contextualised within a One Health framework, highlighting the fragmentation of veterinary surveillance and the need for integrated, cross-sector approaches to detect emerging threats. Full article
Show Figures

Graphical abstract

14 pages, 1175 KB  
Article
Clinical Characteristics and Risk Factors for Cryptococcal Meningitis in Non-Acquired Immunodeficiency Syndrome Patients with Pulmonary Cryptococcosis: A 12-Year Hospital-Based Study
by Xiao Dang, Sha-Sha Wu, Lan Zhang, Li-Li Wu, Cai-Lin Guo, Wen Kang, Ye Zhang and Pei Li
Pathogens 2026, 15(6), 560; https://doi.org/10.3390/pathogens15060560 - 22 May 2026
Abstract
In this study, we aimed to investigate the clinical characteristics of pulmonary cryptococcosis (PC) patients without acquired immunodeficiency disease (AIDS). In this retrospective study, a total of 101 patients with non-AIDS PC diagnosed at Tangdu Hospital between January 2014 and October 2025 were [...] Read more.
In this study, we aimed to investigate the clinical characteristics of pulmonary cryptococcosis (PC) patients without acquired immunodeficiency disease (AIDS). In this retrospective study, a total of 101 patients with non-AIDS PC diagnosed at Tangdu Hospital between January 2014 and October 2025 were enrolled. The characteristics of demographic data, underlying diseases, clinical manifestations, laboratory indicators, and clinical outcomes were analyzed. Univariate and multivariate logistic regression analyses were used to identify risk factors for cryptococcal meningitis (CM). Among 101 patients (mean age 53.13 ± 12.31 years; 66.3% male), 56.4% were asymptomatic. Underlying diseases were present in 55.4% (mainly hypertension and diabetes), and CM occurred in 17.8% (18/101). Patients with CM had a higher proportion of underlying diseases (83.3% vs. 49.4%) and lower levels of red blood cells, hemoglobin, total protein, albumin, globulin, and potassium. Multivariate analysis revealed underlying diseases (OR = 7.246, 95% CI: 1.426~55.33), hypoglobulinemia (OR = 0.847, 95% CI: 0.734~0.956), and hypokalemia (OR = 0.177, 95% CI: 0.028~0.778) as independent risk factors for CM. The combined model showed good predictive value (AUC = 0.863). Non-AIDS PC often presents asymptomatically. Patients with underlying diseases, hypoglobulinemia, or hypokalemia are at significantly higher risk for concurrent CM and warrant aggressive central nervous system evaluation. Full article
Show Figures

Figure 1

24 pages, 2060 KB  
Review
Bacteriophage-Based Therapeutics for Bacterial Sexually Transmitted Infections: From Biological Barriers to Translational Strategies
by Nazym Syrym, Bolat Yespembetov, Sabit Kokanov, Aziz Nakhanov, Yerbol Bulatov, Azamat Abdimukhtar, Alinur Toleukhan, Yeldos Serikbay, Aibol Terebay, Aktoty Anarbekova, Kali Tileukhanov, Sabira Alpysbayeva, Makhpal Sarmykova, Bekzat Yerzhigit, Nadezhda Zinina, Marat Suleimenov and Akbope Abdykalyk
Pathogens 2026, 15(6), 559; https://doi.org/10.3390/pathogens15060559 - 22 May 2026
Abstract
Bacterial sexually transmitted and sexually associated infections remain a major global health concern, increasingly complicated by antimicrobial resistance and the limited effectiveness of existing therapies. In this context, bacteriophage-based and phage-derived approaches have re-emerged as potential alternative antibacterial strategies. This narrative review examines [...] Read more.
Bacterial sexually transmitted and sexually associated infections remain a major global health concern, increasingly complicated by antimicrobial resistance and the limited effectiveness of existing therapies. In this context, bacteriophage-based and phage-derived approaches have re-emerged as potential alternative antibacterial strategies. This narrative review examines their applicability across key bacterial pathogens associated with sexually transmitted infections, including Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Treponema pallidum and biofilm-associated bacterial vaginosis, with a particular focus on pathogen-specific biological barriers. Available evidence indicates that the success of phage-based interventions is strongly dependent on factors such as intracellular localisation, structural characteristics of the bacterial envelope and the presence of polymicrobial biofilms. While phage-derived platforms, including endolysins, depolymerases and engineered phages, demonstrate antibacterial activity in experimental settings, their effectiveness is uneven across different pathogens. Biofilm-associated infections appear more accessible to these approaches, whereas intracellular and structurally atypical bacteria are currently considered more challenging targets based on available mechanistic and experimental evidence. These observations highlight the need for pathogen-specific engineering strategies and delivery systems. Overall, phage-based therapeutics in this field should be considered within a framework that integrates biological constraints with targeted antimicrobial design. Full article
Show Figures

Figure 1

Previous Issue
Back to TopTop